...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Non-invasive fluorescent-protein imaging of orthotopic pancreatic-cancer- patient tumorgraft progression in nude mice
【24h】

Non-invasive fluorescent-protein imaging of orthotopic pancreatic-cancer- patient tumorgraft progression in nude mice

机译:裸鼠原位胰腺癌患者肿瘤移植进程的无创荧光蛋白成像

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In order to individualize and therefore have more effective treatment for pancreatic cancer, we have developed a multicolor, imageable, orthotopic mouse model for individual patients with pancreatic cancer by passaging their tumors through transgenic nude mice expressing green fluorescent protein (GFP) and red fluorescent protein (RFP). The tumors acquired brightly fluorescent stroma from the transgenic host mice, which was stably associated with the tumors through multiple passages. In the present study, pancreatic cancer patient tumor specimens were initially established in NOD.CB17-Prkdcscid/NcrCrl (NOD/SCID) mice. The tumors were then passaged orthotopically into transgenic nude mice ubiquitously expressing GFP and subsequently to nude mice ubiquitously expressing RFP. The tumors, with very bright GFP and RFP stroma, were then orthotopically passaged to non-transgenic nude mice. It was possible to image the brightly fluorescent tumors non-invasively longitudinally as they progressed in the non-transgenic nude mice. This non-invasive imageable tumorgraft model will be valuable to screen for effective treatment options for individual patients with pancreatic cancer, as well as for the discovery of improved agents for this treatment-resistant disease.
机译:为了使胰腺癌个性化并因此具有更有效的治疗方法,我们通过将肿瘤转移到表达绿色荧光蛋白(GFP)和红色荧光蛋白的转基因裸鼠身上,为胰腺癌的各个患者开发了一种多色,可成像的原位小鼠模型(RFP)。肿瘤从转基因宿主小鼠身上获得了明亮的荧光基质,并通过多次传代与肿瘤稳定结合。在本研究中,最初在NOD.CB17-Prkdcscid / NcrCrl(NOD / SCID)小鼠中建立了胰腺癌患者的肿瘤标本。然后将肿瘤从原位传给普遍表达GFP的转基因裸鼠,随后传给普遍表达RFP的裸鼠。然后将具有非常亮的GFP和RFP基质的肿瘤原位传给非转基因裸鼠。随着它们在非转基因裸鼠中的进展,有可能以非侵入性的方式纵向成像明亮的荧光肿瘤。这种非侵入性可成像的肿瘤移植模型对于筛选单个胰腺癌患者的有效治疗方案以及发现针对这种治疗耐药性疾病的改良药物具有重要价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号